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Purpose	We sought to describe results of patient-reported outcome measures implemented among primary
care patients with diabetes and explore factors associated with changes in scores over time.
Methods	Two organizations serving diverse patient populations collected the PROMIS-29 survey at baseline
and 3-month follow-up for patients with type 2 diabetes. Bayesian regression analysis was used
to examine the relationship between patient characteristics and changes in PROMIS-29 scores.
Exploratory analyses assessed relationships between goal-setting and changes in scores.
Results 	The study population reported substantially more problems with physical functioning (mean: 42.5 at
Site 1 and 38.9 at Site 2) and pain interference (mean: 58.0 at Site 1 and 61.1 at Site 2) compared
to the general population (mean: 50; standard deviation: 10). At least 33% of patients had a clinically
meaningful change (ie, at least half the standard deviation, or 5 points) in each PROMIS domain. For
pain interference, 55% had no change, 22% improved by 5 or more points, and 23% worsened by 5
or more points. Bayesian regression analyses suggest that chronic conditions, insurance status, and
Hispanic ethnicity are likely associated with decreased functioning over time. Exploratory analyses
found that setting a mental health goal did not appear to be associated with improvement for anxiety
or depression.
Conclusions

 se of patient-reported outcome measures in routine clinical care identified areas of functional
U
limitations among people with diabetes. However, changes in participants’ PROMIS-29 scores over
time were minimal. Research is needed to understand patterns of change in global and domain-specific
functioning, particularly among racial/ethnic minorities. (J Patient Cent Res Rev. 2019;6:135-147.)
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P

erformance measures are commonly used
in value-based payment models as the basis
of payments, incentives, and public quality
reporting.1,2 Many of these performance measures
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use clinical data routinely collected at the point of
care.1 However, there is increasing demand to add
assessment of patient-reported outcomes in routine
clinical care and corresponding performance metrics
based on patient-reported outcome measures (PROMs)
to health care quality assessment.1,2
Currently, only a few existing performance metrics use
a PROM. For example, the Centers for Medicare &
Medicaid Services (CMS) offers incentives for use of
performance measures assessing functional outcomes
in the Comprehensive Care for Joint Replacement
payment model.3 Also, measures assessing the
www.aurora.org/jpcrr
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monitoring and remission of depression use the Patient
Health Questionnaire, a 9-item tool that lets patients
report their symptoms of depression.4 While not
widely adopted as quality measures in the U.S. health
care system, other countries have used PROM-based
performance metrics to evaluate outcomes.5,6
Incorporating PROM data collection into routine
clinical care has been shown to improve patientclinician relationships, advance shared decisionmaking, and improve patient health outcomes.7-10 In
addition, the use of PROMs has been shown to empower
patients to be more involved in their care.10,11 Research
trials have found that PROMs can enhance goal-setting
for diabetes, depression, and other conditions.12,13
Although patient-reported outcome tools are
increasingly being used in routine clinical care, there
are challenges to implementation and interpretation
for patients with complex chronic conditions.10,14-16
Information regarding how to interpret results, the
amount of change to expect over time, and how to
maintain or improve functioning or forestall slow
decline is inadequate.17 There is growing evidence of the
validity of Patient-Reported Outcomes Measurement
Information System (PROMIS®) tools over time with
some clinical populations,18,19 yet data for patients with
diabetes is lacking. The PROMIS tools were developed
with National Institutes of Health funding and include
self-reported measures of global, physical, mental, and
social health. For example, the PROMIS-29 v2.0 profile
is a collection of 4-item short forms assessing anxiety,
depression, fatigue, pain interference (the impact of pain
on one’s ability to perform daily activities), physical
function, sleep disturbance, and ability to participate in
social roles and activities, along with a single item on
pain intensity.20,21 PROMIS tools have high reliability,
have been demonstrated to be valid and responsive
to change in research and clinical populations, are in
the public domain, and have existing infrastructure
to support their use.22-25 Despite this evidence, more
information is needed on expected responses and
how to interpret changes in score over time in specific
PROMIS domains for specific patient groups.
This project sought to fill a gap in existing literature
by describing the results of PROMs, specifically
a PROMIS-29 tool, implemented among primary
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care patients with type 2 diabetes as part of a larger
study assessing the feasibility and usefulness of
PROMs in routine clinical care. This project also
aimed to understand changes in PROM scores over
time by describing their associations with patient
demographics, clinical characteristics, and patient
goals for this patient population.

METHODS

This study was conducted in two primary care
organizations with diverse structures and patient
populations (a Federally Qualified Health Center and
an academic health center), previously described in
detail.16 This project was reviewed and approved by
Chesapeake Research Review, LLC (Columbia, MD)
and the institutional review boards at the participating
sites. A waiver of consent was requested and approved
for the provision of a limited data set that included
necessary clinical data elements, PROM data, and
goal-setting information collected during routine care.
Study Population
The study population included patients with type 2
diabetes who had a hemoglobin A1c of ≥6.5% and a
primary care visit with a participating provider within
the study period (July 1, 2015–May 31, 2016). Each site
had a goal of 200 participants. The target recruitment
number was based on a previous study that showed this
sample was large enough to detect a meaningful effect
size for change in PROMIS-29 score.20,21 Both sites
modified their existing workflows to include PROM
data collection and use of the results for goal-setting
conversations with patients in routine clinical care.
Details on the study population and implementation
strategy have been previously described.16
Data and Measures
We used the PROMIS-29 v2.0 profile.20,21 Norms
for PROMIS-29 were derived for the U.S. general
population in previous work.22 Specifically, PROMIS
questionnaires were administered using a sampling
plan to ensure that each item was administered to at
least 900 respondents from the U.S. general population
and 500 respondents with known chronic medical
conditions.22 A subsample was derived to represent the
U.S. general population in terms of gender, age, race/
ethnicity, and education.26 A T-score of 50 is the mean
of this normative subsample.
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Medical assistants and care managers gave patients a
paper version of the PROMIS-29 at baseline and at the
3-month follow-up visit. Patients generally completed
the form themselves, but staff read the form to patients
if requested and when the form was completed by
telephone. The English version was available and
offered to patients at both sites; Site 1 also offered the
Spanish version.
Patient age, gender, race/ethnicity, preferred language,
and insurance characteristics were obtained from
electronic health records (EHRs) at the participating
sites. Chronic conditions were identified from patient
diagnoses in the EHR and coded using 27 categories
of chronic conditions defined by the CMS Chronic
Conditions Data Warehouse.27 Results for blood
pressure, blood glucose levels (hemoglobin A1c),
and body mass index were obtained from EHR data
and coded based on existing quality measures or
definitions.28,29
Goals
At Site 1, a primary care clinician (or nurse),
nutritionist, or behavioral health provider conducted
goal-setting conversations at a patient visit or over
the telephone after the patient visit. At Site 2, care
managers conducted goal-setting conversations and
participated in the primary care visit. Patient goals
were documented in patient’s words (including
multiple goals when applicable), along with the action
steps (also open-ended text) and the domains within
which the patient wished to focus, using specific fields
to identify the PROMIS-29 domains.
We categorized each patient’s goals and other
frequently mentioned topics into 1 or more
PROMIS-29 domains. Two National Committee
for Quality Assurance staff members independently
categorized patient goals until agreement was reached,
grouped the goal domains into 3 larger categories
(health care goals, health goals, and life goals), and
obtained consensus on the categorization from the
project’s executive committee.
Analysis
PROMIS-29 scoring guidelines were followed —
namely, use of T-scores, which are standardized with
a mean of 50 and standard deviation (SD) of 10.22 The
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means and distributions on each scale at baseline and
follow-up assessments were calculated. We assumed
follow-up scores were missing at random30,31 for this
calculation, meaning the missing values were more
likely a product of the other observed patient-level
variables and not the missing values themselves. To
examine mean scores for baseline and follow-up, we
estimated linear mixed models with random subject
effects to account for the correlation among repeated
observations32,33 using a hierarchical approach that uses
all available data. We chose not to explicitly impute
data because the conclusions would then be sensitive to
assumptions made in the imputing process and because
these models do not require complete cases.
Least squares means, standard errors, and 95%
confidence intervals were estimated from the models.
We also present the magnitude of change from baseline
to follow-up in 5 categories using 0.5 SD (ie, 5 points)
as a clinically meaningful difference.34,35 In the absence
of specific studies evaluating responsiveness to change
in a particular population, an effect size in the range
of 0.33 to 0.50 generally corresponds to a clinically
important difference in PROM outcomes.35,36
We analyzed the association of patient characteristics
with changes in PROMIS-29 scores using Bayesian
regression.36 Bayesian methods allowed us to answer
two questions about the relationship of a patient
characteristic with PROMIS-29 scores: 1) How
strong is the probable association of a patient factor
with outcomes? and 2) How likely is that association?
Bayesian methods also allowed us to take advantage of
all nonmissing data; thus, we were able to use data for
patients with missing follow-up assessments without
having to impute data.
Sampling of posterior distributions was done with
RStanArm, as accessed through R 3.3.3; all other
analyses were done in R 3.3.3 directly.37,38 A weakly
informed prior (Cauchy distribution centered at 0 and
a constant term of 2.5) was used as a conservative
but practical estimate for all regression coefficients.39
The sampler ran 8 chains; each chain collected 5000
samples, although the first 2500 samples in each chain
were discarded to allow for burn-in. Convergence
and possible autocorrelation were assessed using
RStanArm’s Rhat and n_eff estimates.

www.aurora.org/jpcrr
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The regression models all took the following form:
Change in T-score ~ N(β0 + β1(Initial T-score) + β2(Days
from Baseline) + β3(Obese) + β4(High Blood Pressure) +
β5(Hemoglobin A1c > 9.0) + β6(2–4 Chronic Conditions) +
β7(+Chronic Conditions) + β8(Medicare/Medicaid/Dual
Eligible) + β9(Uninsured) + β10(Age 65+) + β11(Female) +
β12(–Hispanic Black) + β13(Hispanic, English-Preferred) +
β14(Hispanic, Spanish-Preferred) + β15(Site),σ2)

For modeling change in T-scores, we excluded
observations when the baseline score on a PROMIS-29
domain was either the highest or the lowest score
possible (therefore allowing either no room for
improvement or for worsening). Because of this
approach, sample sizes ranged from 178 to 246 patients
per domain.
In practice, this exclusion method could reduce
the models’ ability to specify a narrow range of
plausible effect sizes; however, we did not observe
that it introduced noteworthy selection bias. We
evaluated the impact of patient demographic and
clinical characteristics across PROMIS-29 domains
by examining the distribution of their effect estimates
with site included as a covariate. In addition, Markov
chain Monte Carlo (MCMC) simulations were used to
inspect each independent variable’s parameter estimate
for changes in individual PROMIS-29 T-scores. Our
conclusions were consistent across the 6 PROMIS-29
domains, and therefore, we combined results into a
single plot to make a global statement across domains
(after reverse-coding, where appropriate, so that higher
scores were always better). The parameter estimates
from the MCMC simulations were merged together,
resulting in a single vector for each of the common
independent variables. Each vector then represented
an independent variable’s influence over changes in
the PROMIS-29 domains based on the global posterior
distribution.
Descriptive statistics on goal content were calculated,
and exploratory analyses to examine how the content
related to PROMIS-29 anxiety and depression scores
were conducted. We chose these domains because
it was most clear when goals were related to these
domains. We did not test statistical significance due to
small sample sizes for goal types. We compared the
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content of goals among people whose PROMIS-29
scores indicated problems with depression or anxiety
(T-score of ≥55 on either domain, excluding people
without results for the relevant domains) versus those
who did not.
Finally, we plotted the change in PROMIS-29 scores
among all patients (highlighting those who set goals for
mental health and excluding patients missing relevant
PROMIS-29 results at baseline or follow-up, thus
assuming data were missing completely at random).

RESULTS

PROMIS-29 Scores and Change Over Time
The demographic and clinical characteristics of
patients who completed baseline PROMIS-29 data
collection are provided, by site, in Table 1. At baseline,
our study population (n=490) reported more problems
with physical functioning (average of 43 at Site 1
and 39 at Site 2, with higher scores indicating better
functioning) and pain interference (average of 58 at
Site 1 and 61 at Site 2, with lower scores indicating
better functioning) than the general population; both
indicated functioning about 1 SD poorer than the
general population average of 50 (Table 2). For each
domain, at least 35% of patients had a clinically
meaningful change between the baseline and follow-up
assessment (at least 5 points/0.5 SD) in either direction
(Table 3). For example, for pain interference, 55% had
no change, 22% improved by 5 or more points, and
23% worsened by 5 or more points.
Patient Characteristics Affecting Change in
PROMIS-29 Scores
Figure 1 shows the results of Bayesian analyses to
examine the relationship of patient demographic
and clinical characteristics with change scores on
PROMIS-29 domains combined, considering all
other covariates in the model. Results suggest that
having more chronic conditions, public insurance,
and Hispanic ethnicity is likely to be associated with
decreased functioning over time. Patients with 2–4 or 5
or more chronic conditions were more than 80% likely
to have decreased functioning at follow-up assessment;
this is shown by the percentage of the distribution to
the left of 0. The most likely decrease is about 5 points,
identified in the chart by the vertical bar at the median
of the distribution. Having public insurance (Medicare,
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Table 1. Demographic and Clinical Characteristics of Patients Participating in Baseline PROM Data Collection,
by Site

Site 1
Characteristic

Site 2

n

%

n

%

Total patient population

205

100

285

100

Age category
18–54 years
55–64 years
65+ years

92
74
39

44.9
36.1
19.0

102
101
82

35.8
35.4
28.8

Female

114

55.6

179

62.8

Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Other/Multiple races

51
26
113
10

24.9
12.7
55.1
4.8

152
80
13
13

53.3
28.1
4.6
4.6

45

22.0

64

22.5

147

71.7

206

72.3

Primary insurance
Commercial
Medicare/Medicaid/dual eligible
Other

0

0

1

0

Uninsured

13

6.3

14

4.9

Spanish preferred language

72

35.1

3

1.1

Chronic conditions
Diabetes only
2–4 conditions
5+ conditions

16
126
63

7.8
61.5
30.7

11
145
129

3.9
50.9
45.3

Hemoglobin A1c > 9.0

43

21.0

77

27.0

High BP reading (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg)

66

32.2

96

33.7

BMI ≥ 30.0 (obese)

144

70.2

197

69.1

BMI, body mass index; BP, blood pressure; PROM, patient-reported outcome measure.

Medicaid, or both) is also probably associated with
decreased functioning (most of the distribution is to
the left of 0), but the effect is smaller and the range
of probable effects narrower. Hispanic patients (with
either Spanish- or English-language preference) are
also at least 80% likely to have decreased functioning.
Relationship of Goals to Change in PROMIS-29
Scores
The proportion of patients who set a goal varied by
site, with 40% at Site 1 versus 90% at Site 2; at Site 2,
care managers more consistently worked with patients
to identify a goal (Table 4). Nearly all patients who
set a goal focused on a health-related topic; however,
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mental health (28%) and exercise goals (25%) were
most common at Site 1, whereas diet (34%), weight
loss (26%), and exercise goals (25%) were most
common at Site 2. In many cases, goals addressed
multiple topics.
To explore the association of goals with PROMIS-29
scores, we focused on mental health goals and their
potential association with scores on the PROMIS-29
anxiety and depression domains. Patients who scored
high on anxiety or depression tended to be more likely
to set a goal (eg, 42% vs 37% at Site 1) and to identify
a mental health goal (32% vs 23% at Site 1) (Table 4).
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Table 2. Mean Scores for Baseline and Follow-Up PROMIS-29 Domain, by Site*
Site 1
Domain

Site 2

Data
Collection

Mean

95%
Lower CI

95%
Upper CI

Mean

95%
Lower CI

95%
Upper CI

Baseline

42.5

41.1

43.9

38.9

37.7

40.0

HIGHER IS BETTER
Physical function
Ability to participate in
social roles and activities

Follow-up

41.5

40.0

43.0

38.7

37.4

39.9

Baseline

49.9

48.4

51.5

48.6

47.3

49.9

Follow-up

49.8

48.1

51.5

49.2

47.7

50.6

LOWER IS BETTER
Anxiety
Depression
Fatigue
Sleep disturbance
Pain interference

Baseline

53.2

51.7

54.6

52.7

51.5

53.9

Follow-up

55.9

54.3

57.5

54.3

53.0

55.7

Baseline

54.4

52.8

55.9

53.1

51.9

54.4

Follow-up

54.7

53.0

56.3

52.2

50.8

53.5

Baseline

51.2

49.6

52.7

56.8

55.5

58.1

Follow-up

52.9

51.3

54.6

55.6

54.1

57.1

Baseline

54.5

53.2

55.8

54.5

53.2

55.8

Follow-up

53.5

52.1

55.0

53.1

51.7

54.5

Baseline

58.0

56.4

59.5

61.1

59.9

62.4

Follow-up

58.5

56.9

60.2

60.2

58.9

61.6

*Accounting for missing follow-up data.

Table 3. Change in PROMIS-29 Scores Between Baseline and Follow-Up
Total
Improved at Improved 0.5 SD Minimal Change Worse by 0.5 SD
NonLeast 1 SD
(Change of -5 to
(Between -5
(Change of 5 to Worse by 1 SD
missing (Change ≥ -10) Less Than -10
and 5)
Less Than 10) (Change ≥ 10)
N*

n

%

n

%

n

%

n

%

n

%

Physical function

356

30

8.4

42

11.8

230

64.6

32

9.0

22

6.2

Ability to participate
in social roles and
activities

332

42

12.7

50

15.1

147

44.3

45

13.6

48

14.5

Anxiety

352

41

11.6

32

9.1

162

46.0

46

13.1

71

20.2

Depression

349

41

11.7

47

13.5

190

54.4

38

10.9

33

9.5

Fatigue

348

55

15.8

49

14.1

142

40.8

42

12.1

60

17.2

Sleep disturbance

350

61

17.4

40

11.4

166

47.4

50

14.3

33

9.4

Pain interference

344

39

11.3

36

10.5

190

55.2

42

12.2

37

10.8

HIGHER IS BETTER

LOWER IS BETTER

*n’s vary because not all patients could be scored on all domains at both time periods.
SD, standard deviation.

Setting a mental health goal did not appear to be
associated with reductions in anxiety or depression
(Figures 2 and 3). For example, as shown for anxiety
in Figure 2, there is not a clear pattern of patients who
set a mental health goal (shown in black triangles)
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compared to other patients (gray dots). Most patients
had minimal change (<5 points) in their anxiety score
─ these are the dots and triangles in between the dashed
lines. More patients reported their anxiety worsened
(shown by dots above the upper solid line) than
Original Research

Figure 1. Relationship of

Variable

Probability of
Harmful Effect

Central 80% Interval

Obese

65.0%

-2.57

1.43

High blood pressure

42.0%

-1.92

2.92

HbA1c > 9.0

56.1%

-2.98

2.17

2–4 chronic conditions

86.2%

-14.63

1.14

5+ chronic conditions

87.2%

-14.24

0.99

Medicare/Medicaid/dual eligible

90.0%

-5.40

-0.05

Uninsured

69.7%

-7.77

2.81

Age 65+ years

32.0%

-1.64

4.53

Female gender

81.6%

-3.30

0.46

Non-Hispanic black race

32.1%

-1.34

2.98

Hispanic (Spanish-preferred)

84.2%

-4.37

0.72

Hispanic (English-preferred)

87.0%

-5.88

0.29

improved (shown by dots below the lower solid line).
Of note, some patients who reported no problems at
baseline had scores above the population average score
of 50 at follow-up, and patients with scores above the
mean at baseline often reported the lowest score at
follow-up (dots/triangles on x and y axes).
For depression (Figure 3), most patients had changes
less than 10 points (in either direction), but patterns
related to lowest scores also are evident.

DISCUSSION

This work is among the first to document PROMIS-29
results over time in a population with type 2 diabetes
identified in a routine clinical care setting.40,41 Our study
Original Research

patient factors to changes
in PROMIS-29 scores.
Bayesian regression
models were used for
this analysis. The chart
summarizes distribution of
effects of the independent
variable on the change
in the PROMIS score
across all domains after
reverse-coding, where
appropriate, so higher is
always better. The table
shows the probability that
each patient characteristic
is associated with worsethan-average changes in
PROMIS results over time,
and the central 80% region
of estimated effect sizes.

population reported more problems with physical
functioning and pain interference than the general
population. Overall, our results are consistent with
a previous study that found little change in patientreported outcomes over time for most primary care
patients.17 The finding that most patients had minimal
change is not a surprise since the goal-setting
intervention was not intensive. Our exploratory
analyses did not suggest a link between setting mental
health goals and improvement in PROMIS-29 scores
at follow-up. The clustering of responses at the lowest
point of the scores (indicating no problems) warrants
greater investigation. Also, while we were not
surprised to find that chronic conditions and public
insurance were associated with a greater probability
www.aurora.org/jpcrr
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Table 4. Content of Goals for Patients With Functional Limitations Based on PROMIS-29 Anxiety and
Depression Scores, by Site

Type of Goal

Anxiety or
Depression
n
%

Site 1

No Anxiety or
Depression
n
%

Anxiety or
Depression
n
%

Site 2

No Anxiety or
Depression
n
%

Number of patients

118

100

82

100

163

100

121

100

At least one goal

50

42.4

30

36.6

150

92.0

106

87.6

Health

46

92.0

29

96.7

132

88.0

92

86.8

Diet

9

18.0

4

13.3

52

34.7

35

33.0

Lose weight

6

12.0

2

6.7

33

22.0

33

31.1

Exercise

10

20.0

10

33.3

29

19.3

33

31.1

Reduce pain

9

18.0

2

6.7

34

22.7

17

16.0

Physical function

7

14.0

1

3.3

12

8.0

7

6.6

Mental health*

16

32.0

7

23.3

15

10.0

1

0.9

Stop smoking

2

4.0

0

0.0

9

6.0

6

5.7

Sleep

6

12.0

6

20.0

7

4.7

2

1.9

Fatigue

2

4.0

0

0.0

3

2.0

1

0.9

Maintain weight

0

0.0

0

0.0

1

0.7

0

0.0

Meditation

0

0.0

2

6.7

1

0.7

0

0.0

8

16.0

2

6.7

67

44.7

31

29.2

Reduce glucose level

0

0.0

1

3.3

27

18.0

19

17.9

Other clinical issue

2

4.0

0

0.0

29

19.3

13

12.3

Medication-related

5

10.0

2

6.7

23

15.3

8

7.5

Diabetes supplies

0

0.0

0

0.0

5

3.3

2

1.9

Other goal

1

2.0

0

0.0

3

2.0

0

0.0

Transportation

2

4.0

0

0.0

2

1.3

0

0.0

7

14.0

1

3.3

20

13.3

5

4.7

Social

5

10.0

1

3.3

9

6.0

4

3.8

Home-related

1

2.0

0

0.0

8

5.3

3

2.8

Financial help

0

0.0

0

0.0

5

3.3

0

0.0

Hobby

1

2.0

0

0.0

2

1.3

0

0.0

Spiritual health

0

0.0

0

0.0

1

0.7

0

0.0

Health care

Life

*Functional limitation was defined as T-score of 55 or greater on the PROMIS anxiety or depression scale (where mean is 50 and
standard deviation is 10). Excludes patients who did not have a score on either of the anxiety and depression scales at baseline.

of decreased functioning over time, the probable
relationship with Hispanic ethnicity is of interest.
Our study offers support and direction for future research
to understand the patterns of change and improvement
in functional status among patients in primary care and
the extent of their sensitivity to goal-setting and careplanning interventions. In particular, research should
142 JPCRR • Volume 6, Issue 2 • Spring 2019

explore the variability of PROMIS-29 scores and
evaluate whether responses clustered at the lowest point
of the score (indicating no problems) occurs in other
settings and with varying implementation strategies.
Also, research should explore language and ethnicity to
consider whether the finding of a relationship between
Hispanic ethnicity and decreased functioning over time
is borne out in larger, more robust studies.
Original Research

Figure 2. Change in PROMIS-29 anxiety score among patients who set/did not set a mental

health goal at baseline (both sites combined). Baseline anxiety score is on the horizontal axis
(higher scores indicate worse anxiety). Follow-up score is on the vertical axis. Each patient is a
dot. Black triangle dots represent patients who set a mental health goal, and gray circular dots
represent patients who did not set a mental health goal. Only patients with scores at both baseline
and follow-up are represented. Patients who fall between the dashed lines had minimal change
between baseline and follow-up (<5 points in either direction). Patients between the solid lines
had a change that was <1 SD (<10 points). Patients above the top solid line had an anxiety
score worse by >1 SD at follow-up. Patients below the bottom solid line had an anxiety score that
improved by >1 SD at follow-up. Columns at the right and top of the chart show the histograms
(number of patients with that score) for each point on the axis.
Results show that most patients are in the middle, with minimal change, but more patients
reported that their anxiety was worse. The dots clustered at the origin represent patients who had
the lowest score possible at both baseline and follow-up. A number of patients who reported no
problems at baseline had scores above the population average (ie, 50) at follow-up; patients with
scores above the population average at baseline often reported the lowest score at follow-up.

Original Research
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Figure 3. Change in PROMIS-29 depression score among patients who set/did not set a mental

health goal at baseline (both sites combined). Baseline depression score is on the horizontal axis.
Higher scores indicate worse depression. Follow-up score is on the vertical axis. Each patient is
a dot. Black triangle dots represent patients who set a mental health goal, and gray circular dots
represent patients who did not set a mental health goal. Only patients with scores at both baseline
and follow-up are represented. Patients who fall between the dashed lines had minimal change
between baseline and follow-up (<5 points in either direction). Patients between the solid lines had
a change that was <1 SD (<10 points). Patients above the top solid line had a depression score
worse by >1 SD at follow-up. Patients below the bottom solid line had a depression score that
improved by >1 SD at follow-up. Columns at the right and top of the chart show the histograms
(number of patients with that score) for each point on the axis.
Results show that most patients are in the middle, with no change. The dots clustered at the origin
represent patients who had the lowest score possible at both baseline and follow-up. A number
of patients who reported no problems at baseline had scores above the average 50 at follow-up;
patients with scores above the mean at baseline often reported the lowest score at follow-up.
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Given the site-specific differences in goal-setting
implementation and the anticipated challenges with
incorporating PROMs and patient goals into practice
EHRs and overall workflow, future research should
explore effective methods of PROM implementation.
For example, human-factor research methods42 could
play an important role in improving use of patientreported outcome data in clinical care by helping
identify mental models that guide patient engagement
and clinical decision-making, patient cultural and
language needs, and workflows for data collection
and follow-up. To support this work, we believe that
it will be important first to gather sufficient data to
provide patients, clinicians, and other members of the
care team information on PROMIS-29 scores and how
they can be used to improve clinical management and
treatment as well as monitor outcomes.
Limitations
The generalizability of findings from this pilot
feasibility study is limited because it was conducted
at only two sites, included only patients with type 2
diabetes, and used a single PROM tool (PROMIS-29).
Although changes in PROMIS-29 scores were assessed
over a 3-month period, longer longitudinal studies are
needed to truly determine clinical relevance. Sites did
not use electronic data collection for PROM results or
for tracking patients over time due to the significant
costs and resources needed to modify practice EHRs.
This may have impacted provider engagement in the
goal-setting process.
The two sites varied in both their patient population
and workflow/care team, so our ability to tease out
these factors is limited. The timing of follow-up and
documentation of missing data varied due to differences
in staffing, workflows, and other competing demands
in these busy primary care settings. Despite these
limitations, the study is important for capturing data
on PROMs in settings serving diverse populations,
and the participating sites — a Federally Qualified
Health Center and an academic clinic — are likely
generalizable to comparable settings.

CONCLUSIONS

The use of patient-reported outcome measures in
routine clinical care identified areas of functional
limitations among people with diabetes, particularly in
pain interference and physical functioning. However,
Original Research

changes in PROMIS-29 scores over time without
targeted intervention were limited. As increased
emphasis is placed on using PROMs in routine
clinical care and performance measurement, additional
research is needed to understand patterns of change in
global and domain-specific functioning, particularly
among racial/ethnic minorities, as well as the best
ways to use these data in care planning. Future studies
should consider the cost of implementation along with
potential changes in PROM scores to conduct costbenefit analyses.

Patient-Friendly Recap
• Patient-reported outcomes include any report
of health status that comes directly from the
patient, for example, an answer to a survey
asking how much pain they feel.
• PROMIS-29 is a survey designed to obtain
and measure patient-reported quality of life.
• The authors tested which factors contributed
to changes in outcomes (ie, better or worse
quality of life) for patients with type 2 diabetes
visiting a primary care clinic.
• Use of PROMIS-29 identified that, over 3
months, decreased physical function was
associated with number of chronic conditions,
insurance status, and Hispanic ethnicity.
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